Literature DB >> 10655550

The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes.

M M Ouellette1, L D McDaniel, W E Wright, J W Shay, R A Schultz.   

Abstract

The limited life span of normal human cells represents a substantial obstacle for biochemical analysis, genetic manipulation and genetic screens. To overcome this technical barrier, immortal human cell lines are often derived from tumors or produced by transformation with viral oncogenes such as SV40 large T antigen. Cell lines produced by these approaches are invariably transformed, genomically unstable and display cellular properties that differ from their normal counterpart. It was recently shown that the ectopic expression of hTERT, encoding the catalytic subunit of human telomerase, can extend the life span of normal human cells without causing cellular transformation and genomic instability. In the present study, we have used hTERT to extend the life span of normal human skin fibroblasts derived from patients afflicted with syndromes of genomic instability and/or premature aging. Our results show that hTERT efficiently extends the life span without altering the characteristic phenotypic properties of the cells. Thus, the ectopic expression of telomerase represents a major improvement over the use of viral oncogenes for the establishment of human cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655550     DOI: 10.1093/hmg/9.3.403

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  83 in total

1.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 2.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

3.  Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.

Authors:  Yongli Bai; John P Murnane
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

4.  Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence.

Authors:  Erica K Benson; Sam W Lee; Stuart A Aaronson
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

5.  Purine receptors and Ca(2+) signalling in the human blood-brain barrier endothelial cell line hCMEC/D3.

Authors:  Willem Bintig; Daniela Begandt; Barbara Schlingmann; Linda Gerhard; Maria Pangalos; Lutz Dreyer; Natalija Hohnjec; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Anaclet Ngezahayo
Journal:  Purinergic Signal       Date:  2011-09-29       Impact factor: 3.765

Review 6.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

7.  Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells.

Authors:  J C Y Wang; J K Warner; N Erdmann; P M Lansdorp; L Harrington; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

8.  Telomere dysfunction as a cause of genomic instability in Werner syndrome.

Authors:  Laure Crabbe; Anna Jauch; Colleen M Naeger; Heidi Holtgreve-Grez; Jan Karlseder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

9.  Use of exogenous hTERT to immortalize primary human cells.

Authors:  Kwang M Lee; Kyung H Choi; Michel M Ouellette
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

10.  BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks.

Authors:  Pietro Pichierri; Annapaola Franchitto; Filippo Rosselli
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.